Current guidelines recommend anticoagulant therapy with vitamin K antagonists, such as warfarin, for just 3-6 months after bioprosthetic valve replacement, even for patients in sinus rhythm.

Izumi noted that NOACs have been increasingly used at discharge for patients following bioprosthetic valve replacement “despite this being an off-label use for patients with sinus rhythm.” But ...

The randomized, multi-center trial included approximately 400 adults in Japan who had bioprosthetic heart valve replacement surgery at the aortic and/or mitral position. Researchers randomized the ...

MEDLINE 16. David TE, Ivanov J, Armstrong S, Feindel CM, Cohen G: Late results of heart valve replacement with the Hancock II bioprosthesis. J Thorac Cardiovasc Surg 2001; 121: 268–77.

AHA 2024 Anticoagulant Considered After Bioprosthetic Valve Surgery Edoxaban was at least as effective as warfarin in preventing thromboembolism after bioprosthetic valve replacement in the ENBALV ...

The randomized, multi-center trial included approximately 400 adults in Japan who had bioprosthetic heart valve replacement surgery at the aortic and/or mitral position. Researchers randomized the ...

A farmer and teacher by profession, he exemplified the spirit of resilience, undergoing an extraordinary medical journey to ...

Current guidelines recommend anticoagulant therapy for 3-6 months following bioprosthetic valve replacement, including in patients with sinus rhythm, but only warfarin is recommended and approved ...

The randomized, multi-center trial included approximately 400 adults in Japan who had bioprosthetic heart valve replacement surgery at the aortic and/or mitral position. Researchers randomized the ...

Patients who receive a heart valve replacement are well-known to be ... Patients who receive a bioprosthetic (made with human or animal tissue) heart valve typically need anticoagulants for ...